We first compared the expression levels of BRD2, BRD3, and BRD4 in ACC patients with different cancer stages and found that the BRD3 (stage 4) and BRD4 transcript levels were significantly upregulated in patients with ACC (P < 0.05) (Figures 1B, C). This evidence concerns the gene BRD2 and adrenal cortex carcinoma.